PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis

Area of Science:

• Endocrinology
• Molecular Biology
• Cardiovascular Research

Background:

• Nuclear receptors regulate gene expression in response to hormones and metabolites.
• Liver X receptors (LXRs) and peroxisome proliferator-activated receptors (PPARs) are critical subclasses.
• LXRs and PPARs are implicated in cholesterol, lipid, and glucose homeostasis.

Purpose of the Study:

• To review recent studies on the biological roles and mechanisms of LXRs and PPARs.
• To provide insights into how these nuclear receptors influence systemic lipid and glucose metabolism.
• To examine their role in regulating gene expression within the artery wall.

Main Methods:

• Review of recent intervention studies and research findings.
• Analysis of mechanisms by which LXRs and PPARs influence metabolic pathways.
• Examination of gene expression regulation in the context of atherosclerosis.

Main Results:

• LXRs are crucial for cholesterol absorption, excretion, and lipoprotein metabolism.
• PPARs regulate fatty acid oxidation, adipogenesis, lipoprotein metabolism, and glucose homeostasis.
• Activation of PPARalpha, PPARgamma, and LXRs can inhibit atherosclerosis in animal models.

Conclusions:

• LXRs and PPARs are vital regulators of systemic lipid and glucose metabolism.
• Synthetic ligands targeting these receptors show potential for atherosclerosis intervention.
• Further research into their mechanisms can illuminate therapeutic strategies for metabolic and cardiovascular diseases.